close
MENU
Investment
2 mins to read

Trump tariffs a negative for F&P Healthcare, say analysts

A research note from Craigs models three scenarios on US tariffs but sees current year profit at top end of guidance.

Respiratory care products maker Fisher & Pakel Healthcare gets about 40% of its revenue from the US.

NBR Staff Tue, 28 Jan 2025

Medical device maker Fisher & Paykel Healthcare faces a significant impact from potential tariffs in the US, say research analysts, even though it can raise prices to offset the cost.

In a research note issued on Monday, Stephen Ridgewell and Rob Morrison of Craigs Investment Partners said tariffs

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Smartphone Only Annual Subscription

NZ$249.00 / yearly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Subscription

NZ$29.95 / monthly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
NBR Staff Tue, 28 Jan 2025
Contact the Writer: editor@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Trump tariffs a negative for F&P Healthcare, say analysts
Investment,
107551
true